Most Employers’ Retiree Rx Coverage Will Continue After Medicare Part D – Survey
This article was originally published in The Pink Sheet Daily
Kaiser Family Foundation/Hewitt survey finds 58% of large employers plan to accept the government subsidy to continue offering retiree drug benefits that are actuarially equivalent to Part D. Only 8% expect to discontinue retiree Rx coverage.
You may also be interested in...
Companies will accept the government subsidy for retirees’ drug coverage initially, but will move former workers to the Medicare drug benefit in later years, executives from Kaiser Foundation Health Plans and the Employers Coalition on Medicare predict.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.